Chargement en cours...

High-throughput approaches to discover novel immunomodulatory agents for cancer

The clinical success of immunomodulatory thalidomide derivatives has renewed the general interest in immunomodulatory anticancer compounds and prompted us to develop a high-throughput system to quantify immune effector-cell activity. We documented that the interaction between cancer cells, their str...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: McMillin, Douglas W., Mitsiades, Constantine S.
Format: Artigo
Langue:Inglês
Publié: Landes Bioscience 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3518518/
https://ncbi.nlm.nih.gov/pubmed/23243609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21058
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!